hepatect cp 50 iu/ml; solution for infusion
biotest pharma gmbh - human plasma protein; hbs antibodies - solution for infusion - 50 international unit(s)/millilitre - specific immunoglobulins; hepatitis b immunoglobulin
hepatect cp solution for infusion 50 iuml
grifols asia pacific pte. ltd. - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - infusion, solution - 50 iu/ml - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 50 iu/ml
zutectra solution for injection 500 iuml
eshcol pharmaceutical group singapore pte ltd - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) - injection - 500 iu/ml - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) 500 iu/ml
niuliva solution for infusion 250 i.u.ml
grifols asia pacific pte. ltd. - human antihepatitis b immunoglobulin - injection, solution - 250 i.u./ml - human antihepatitis b immunoglobulin 250 i.u./ml
megalotect cp solution for infusion 100 uml
grifols asia pacific pte. ltd. - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - injection - 100 u/ml - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 100 u/ml
rhophylac 1,500units/2ml solution for injection pre-filled syringes
csl behring uk ltd - anti-d (rho) immunoglobulin - solution for injection - 750unit/1ml
rhophylac 300 solution for i/v and i/m injection
csl behring ag - immunoglobulin anti-d (rh) human - solution for i/v and i/m injection - 300mcg/2ml
zutectra
kamada ltd, israel - human hepatitis b immunoglobulin - solution for injection - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure.hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start.the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.
hyperhep b pre-filled syringe 0.5ml
grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%
hyperhep b pre-filled syringe 1ml
grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%